Pediatric Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Clinical Presentation, Infectivity, and Immune Responses.

"Supported by the 10.13039/100000050National Heart, Lung, and Blood Institute (5K08HL143183 to L.Y.), the 10.13039/100000897Cystic Fibrosis Foundation (YONKER18Q0 to L.Y.), the 10.13039/100000071National Institute of Child Health and Human Development (K08 HD094638 [to A.N.] and R01HD100022 [to A.E.]), Mark and Lisa Schwartz (to J.L.), the 10.13039/100000062National Institute of Diabetes and Digestive and Kidney Diseases (DK039773, DK072381 [to J.B.] and DK104344 [to A.F.]), the 10.13039/100000060National Institute of Allergy and Infectious Disease (K24AI141036 to I.B.), the 10.13039/100000030Centers for Disease Control and Prevention (U01CK000490 to E.R.), and the Department of Pediatrics and the Department of Obstetrics/Gynecology at 10.13039/100005294Massachusetts General Hospital (to L.Y. and A.E.). The authors declare no conflicts of interest."

"Supported by the 10.13039/100000050National Heart, Lung, and Blood Institute (5K08HL143183 to L.Y.), the 10.13039/100000897Cystic Fibrosis Foundation (YONKER18Q0 to L.Y.), the 10.13039/100000071National Institute of Child Health and Human Development (K08 HD094638 [to A.N.] and R01HD100022 [to A.E.]), Mark and Lisa Schwartz (to J.L.), the 10.13039/100000062National Institute of Diabetes and Digestive and Kidney Diseases (DK039773, DK072381 [to J.B.] and DK104344 [to A.F.]), the 10.13039/100000060National Institute of Allergy and Infectious Disease (K24AI141036 to I.B.), the 10.13039/100000030Centers for Disease Control and Prevention (U01CK000490 to E.R.), and the Department of Pediatrics and the Department of Obstetrics/Gynecology at 10.13039/100005294Massachusetts General Hospital (to L.Y. and A.E.). The authors declare no conflicts of interest."